Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.35 - $3.28 $9,735 - $91,233
27,815 Added 29.82%
121,099 $42,000
Q1 2023

May 12, 2023

BUY
$3.28 - $4.81 $63,363 - $92,919
19,318 Added 26.12%
93,284 $322,000
Q4 2022

Feb 08, 2023

BUY
$3.65 - $4.82 $144,543 - $190,876
39,601 Added 115.24%
73,966 $331,000
Q3 2022

Nov 10, 2022

SELL
$2.66 - $3.97 $1,157 - $1,726
-435 Reduced 1.25%
34,365 $125,000
Q2 2022

Aug 10, 2022

SELL
$2.42 - $4.05 $299,387 - $501,041
-123,714 Reduced 78.05%
34,800 $92,000
Q1 2022

May 16, 2022

SELL
$3.45 - $5.83 $318,127 - $537,590
-92,211 Reduced 36.78%
158,514 $622,000
Q4 2021

Feb 14, 2022

BUY
$4.89 - $7.59 $200,494 - $311,197
41,001 Added 19.55%
250,725 $1.38 Million
Q3 2021

Nov 15, 2021

BUY
$5.18 - $7.41 $297,093 - $424,993
57,354 Added 37.64%
209,724 $1.51 Million
Q2 2021

Aug 13, 2021

SELL
$3.94 - $6.75 $487,673 - $835,481
-123,775 Reduced 44.82%
152,370 $1.01 Million
Q1 2021

May 12, 2021

SELL
$4.03 - $7.25 $75,957 - $136,648
-18,848 Reduced 6.39%
276,145 $1.2 Million
Q4 2020

Feb 11, 2021

BUY
$2.78 - $4.5 $194,419 - $314,707
69,935 Added 31.07%
294,993 $1.13 Million
Q3 2020

Nov 12, 2020

BUY
$2.12 - $3.53 $10,534 - $17,540
4,969 Added 2.26%
225,058 $787,000
Q2 2020

Jul 31, 2020

BUY
$1.66 - $2.73 $169,411 - $278,610
102,055 Added 86.46%
220,089 $493,000
Q1 2020

May 01, 2020

BUY
$1.35 - $4.05 $145,122 - $435,366
107,498 Added 1020.29%
118,034 $295,000
Q4 2019

Feb 14, 2020

SELL
$2.3 - $4.6 $5,954 - $11,909
-2,589 Reduced 19.73%
10,536 $45,000
Q3 2019

Nov 14, 2019

SELL
$2.9 - $9.56 $32,335 - $106,594
-11,150 Reduced 45.93%
13,125 $38,000
Q2 2019

Aug 14, 2019

SELL
$6.7 - $9.13 $91,461 - $124,633
-13,651 Reduced 35.99%
24,275 $214,000
Q1 2019

May 14, 2019

SELL
$5.7 - $8.73 $1.97 Million - $3.02 Million
-345,784 Reduced 90.12%
37,926 $280,000
Q4 2018

Feb 14, 2019

BUY
$5.04 - $10.28 $1.61 Million - $3.29 Million
320,435 Added 506.42%
383,710 $2.33 Million
Q3 2018

Nov 14, 2018

BUY
$7.12 - $12.44 $74,218 - $129,674
10,424 Added 19.72%
63,275 $592,000
Q2 2018

Aug 14, 2018

BUY
$6.21 - $8.21 $107,594 - $142,246
17,326 Added 48.77%
52,851 $366,000
Q1 2018

May 15, 2018

BUY
$6.26 - $10.12 $203,863 - $329,567
32,566 Added 1100.57%
35,525 $228,000
Q4 2017

Feb 14, 2018

BUY
$5.6 - $9.9 $3,645 - $6,444
651 Added 28.21%
2,959 $27,000
Q3 2017

Nov 14, 2017

BUY
$4.73 - $6.16 $4,886 - $6,363
1,033 Added 81.02%
2,308 $13,000
Q2 2017

Aug 14, 2017

SELL
N/A
-21,204 Reduced 94.33%
1,275 $8,000
Q1 2017

Nov 14, 2017

BUY
N/A
22,479
22,479 $192,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.